Price to Earnings (P/E)
since 2005
Paying user area
Try for free
Cigna Group pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Income Statement
- Analysis of Liquidity Ratios
- Analysis of Reportable Segments
- Present Value of Free Cash Flow to Equity (FCFE)
- Operating Profit Margin since 2005
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Total Asset Turnover since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Cigna Group for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Cigna Group, P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Shareholders’ net income1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 29, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 29, 2008 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2007 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Cigna Group Annual Report.
- Share Price Trend
- The share price exhibited notable fluctuations over the period analyzed. Initially, the price remained relatively stable around the low 40s US dollars from 2006 to early 2008. A sharp decline was observed in 2009, dropping to approximately 16.39 US dollars, representing a significant decrease likely influenced by broader market conditions. Following this trough, the share price demonstrated consistent recovery and growth, reaching a peak of 336.14 US dollars in 2024 before experiencing a moderate decline to 302.92 US dollars in 2025. This overall trend suggests robust long-term growth despite short-term volatilities.
- Earnings per Share (EPS) Trend
- The EPS showed considerable volatility throughout the years. Between 2006 and 2009, earnings per share dropped markedly from 4.47 to 1.08 US dollars, signaling a period of financial challenge or restructuring. From 2010 onward, EPS generally trended upward with intermittent fluctuations, peaking notably at 24.04 US dollars in 2021. However, post-2021, EPS levels declined to 12.55 US dollars by 2025, indicating possible earnings pressure or strategic shifts impacting profitability. The wide range in EPS values reflects periods of both expansion and contraction in earnings performance.
- Price-to-Earnings (P/E) Ratio Analysis
- The P/E ratio varied significantly across the timeline. During the early years, it remained below 15, with a low of 7.15 in 2010, suggesting comparatively undervalued earnings relative to price at that time. From 2011 to 2019, there was a clear upward trajectory in the P/E ratio, reaching as high as 25.14 in 2019, indicative of increased market expectations or higher valuation premiums. The ratio then dropped sharply in 2020 and 2021, reaching lows around 8.71, coinciding with the period of EPS peak and subsequent share price fluctuations. In recent years, the P/E ratio climbed again, rising to 24.14 in 2025, suggesting that the market continues to place significant valuation emphasis despite a declining EPS.
- Overall Financial Insights
- The data reveals a company experiencing cyclical earnings and valuation adjustments over nearly two decades. The sharp EPS decline in 2009 and corresponding share price drop indicate susceptibility to adverse economic conditions. However, the recovery and subsequent growth in share price demonstrate resilience and market confidence over the long term. The rising P/E ratio during growth phases reflects optimism about future earnings potential, though recent divergence between earnings and market valuation suggests investor expectations remain high even as earnings have tapered off. This pattern underscores the importance of monitoring both profitability and market sentiment when assessing financial health and investment appeal.
Comparison to Competitors
Cigna Group, P/E, long-term trends, comparison to competitors
| Cigna Group | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Feb 27, 2025 | ||||||
| Feb 29, 2024 | ||||||
| Feb 23, 2023 | ||||||
| Feb 24, 2022 | ||||||
| Feb 25, 2021 | ||||||
| Feb 27, 2020 | ||||||
| Feb 28, 2019 | ||||||
| Feb 28, 2018 | ||||||
| Feb 23, 2017 | ||||||
| Feb 25, 2016 | ||||||
| Feb 26, 2015 | ||||||
| Feb 27, 2014 | ||||||
| Feb 28, 2013 | ||||||
| Feb 23, 2012 | ||||||
| Feb 25, 2011 | ||||||
| Feb 25, 2010 | ||||||
| Feb 26, 2009 | ||||||
| Feb 29, 2008 | ||||||
| Feb 28, 2007 | ||||||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Cigna Group, P/E, long-term trends, comparison to sector (health care equipment & services)
| Cigna Group | Health Care Equipment & Services | |
|---|---|---|
| Feb 27, 2025 | ||
| Feb 29, 2024 | ||
| Feb 23, 2023 | ||
| Feb 24, 2022 | ||
| Feb 25, 2021 | ||
| Feb 27, 2020 | ||
| Feb 28, 2019 | ||
| Feb 28, 2018 | ||
| Feb 23, 2017 | ||
| Feb 25, 2016 | ||
| Feb 26, 2015 | ||
| Feb 27, 2014 | ||
| Feb 28, 2013 | ||
| Feb 23, 2012 | ||
| Feb 25, 2011 | ||
| Feb 25, 2010 | ||
| Feb 26, 2009 | ||
| Feb 29, 2008 | ||
| Feb 28, 2007 | ||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Cigna Group, P/E, long-term trends, comparison to industry (health care)
| Cigna Group | Health Care | |
|---|---|---|
| Feb 27, 2025 | ||
| Feb 29, 2024 | ||
| Feb 23, 2023 | ||
| Feb 24, 2022 | ||
| Feb 25, 2021 | ||
| Feb 27, 2020 | ||
| Feb 28, 2019 | ||
| Feb 28, 2018 | ||
| Feb 23, 2017 | ||
| Feb 25, 2016 | ||
| Feb 26, 2015 | ||
| Feb 27, 2014 | ||
| Feb 28, 2013 | ||
| Feb 23, 2012 | ||
| Feb 25, 2011 | ||
| Feb 25, 2010 | ||
| Feb 26, 2009 | ||
| Feb 29, 2008 | ||
| Feb 28, 2007 | ||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).